Skip to content

Development of a tin oxide carrier with mesoporous structure for improving the dissolution rate and oral relative bioavailability of fenofibrate

· 0 citations · 49 references

TL;DR

In vitro release tests demonstrated that MSn with a good biocompatibility could effectively enhance the dissolution rate of FNB and Pharmacokinetic results indicated that MSn significantly increased the oral relative bioavailability of FNB.

View source

Similar papers

Open access Sep 2026

In vitro evaluation of water-insoluble silicates and polyvinylpyrrolidone-vinyl acetate as oral carriers for amorphous ritonavir: dissolution enhancement and the role of phosphatidylcholine.

Porous silicates have been investigated as drug carriers to promote the solubility and in vitro dissolution of poorly water-soluble drugs, owing to their potential to adsorb drug molecules in the amorphous form within their structural cavities. This study aimed to evaluate the efficiency of bentonite (BT), Aeroperl 300...

Gaurav Dhumal, Adélaïde Savoy, M. Kuentz et al. · 0 citations
Open access Aug 2026

Formulation, Characterization and Evaluation of Polymeric Nanospheres-Based Colon-Targeted Delivery of Oxiconazole Nitrate

Oxiconazole nitrate-loaded nanospheres were successfully developed using the emulsification–solvent evaporation method to enhance the solubility and dissolution of oxiconazole nitrate, a Biopharmaceutics Classification System (BCS) Class II antifungal drug characterized by low aqueous solubility and good membrane perme...

Suyash Shashikant Ingle, A. Chavan, Vasundhara Somnath Patil et al. · 0 citations
Open access Aug 2026

Design And Development Of Fast Dissolving Tablets Of Mefenic Acid Prepared By Spherical Crystallization Technique

Mefenamic acid is a Non Steroidal anti- inflammatory drug   belonging to the BCS class II. It has a low oral bioavailability due to poor aqueous solubility and poor dissolution rate. The present study was undertaken to improve the dissolution, absorption, and bioavailability of Mefenamic acid by employing spherical agg...

P. Rambabu, P. Shailaja · 0 citations
Open access Sep 2026

Application of Self-Nanoemulsifying Drug Delivery Systems in Enhancing Dissolution Rate and Pharmacokinetic Performance of Poorly Water-Soluble Pharmaceuticals

Poor aqueous solubility remains the single most common cause of variable and incomplete oral absorption among new chemical entities, with a substantial proportion of marketed and pipeline molecules falling under Biopharmaceutics Classification System (BCS) classes II and IV. Self-nanoemulsifying drug delivery systems (...

Deepa Cherian and Dr. Rakesh Kumar Jat · 0 citations
Open access Aug 2026

Innovative drug-modified low-generation PAMAM dendrimer complexes for enhancing the solubility and permeability of BCS class II and IV drugs.

The aqueous solubility and membrane permeability of Biopharmaceutics Classification System (BCS) class II and IV drugs, such as furosemide (FUR), sulfadiazine (SDZ), verapamil (VEP), mefloquine (MEF), and the bioactive compound quercetin (QUE), are low. Thus, affecting the oral bioavailability of these drugs. In our st...

Felipe Guizze, S. Sueyoshi, Helena Castilho et al. · 0 citations
Open access Aug 2026

Formulation and Evaluation of Hard Gelatine Capsules of Atorvastatin Prepared by Kneading for Enhancement of Oral Bioavailability

Atorvastatin calcium, a widely prescribed HMG-CoA reductase inhibitor used in the management of hypercholesterolemia and dyslipidaemia, belongs to BCS Class II, characterized by low aqueous solubility and consequently poor and variable oral bioavailability (approximately 12–14%). This limitation arises primarily from p...

R. Gandhi, V. Gunaseelan, M. Prakash et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.